Cartesian Therapeutics, Inc.

Industry: Biotechnology (See others in industry)

Address:
704 Quince Orchard Rd
Gaithersburg, MD, 20878
Phone: 617-923-1400

Filings

Date Type Incremental Cash Raw Filing
2024-07-17 New $130,023,000 SEC link
2023-12-04 Amended $0 SEC link
2023-12-01 New $60,250,000 SEC link
2020-08-18 New $25,000,000 SEC link
2020-01-02 New $70,000,000 SEC link
2019-09-04 New $5,752,495 SEC link
2017-07-11 New $50,000,000 SEC link
2016-12-14 New $4,999,984 SEC link
2015-09-10 New $37,400,000 SEC link
2015-04-23 New $5,942,306 SEC link
2014-08-28 New $4,450,000 SEC link
2014-07-15 New $6,000,000 SEC link
2014-04-09 New $5,292,702 SEC link
2011-11-17 New $3,500,000 SEC link
2011-11-17 New $22,000,000 SEC link
2010-04-06 New $15,000,006 SEC link
2009-01-05 Paper Filing Unknown Not Available

Directors and Executives (Current and Past)

Name Role
David Abraham Executive
Goran Ando Director
Timothy C. Barabe Director
Robert L. Bratzler Director, Executive
Carsten Brunn Director, Executive
Werner Cautreels Director, Executive
Douglas Cole Director
Carrie S. Cox Director
Bradford D. Dahms Executive
Blaine Davis Executive
Nishan De Silva Director
Cole Douglas Director
Emily English Executive
Omid Farokhzad Director
Carl Gordon Director
Peter Barton Hutt Director
Chris Jewell Executive
Lloyd Johnston Executive
Murat Kalayoglu Director
Edwin M. Kania, Jr. Director
Peter Keller Executive
Takashi Kei Kishimoto Executive
Elona Kogan Executive
Metin Kurtoglu Executive
Robert Langer Director
Robert S. Langer, Jr. Director
Kemal Malik Director
Milos Miljkovic Executive
Scott Myers Director
Amir Nashat Director
Aymeric S. Sallin Director
Earl Sands Executive
Alison Schecter Executive
Leysan Shaydullina Director
George Siber Director
David Siewers Executive
Michael Singer Director
Stephen Smolinksi Executive
Stephen Smolinski Executive
Timothy A. Springer Director
Yuriy Udaltsov Director
Patrick Zenner Director